Tirzepatide (Flexible titration)

DRUG2 trials

Sponsors

Dasman Diabetes Institute, Zagazig University

Conditions

Obese DiabeticsObese Non DiabeticObesity

Phase 3

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

CompletedNCT07820111

Zagazig UniversityObese Diabetics, Obese Non Diabetic

Start: 2025-10-18End: 2026-03-17Updated: 2026-09-15

Unknown Phase

Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

RecruitingNCT07574723

Dasman Diabetes InstituteObesity

Start: 2026-05-15End: 2029-12-31Target: 68Updated: 2026-07-08